Like treatments for high blood pressure or diabetes, they work best when patients receive ongoing care and support
A 2025 study on liraglutide nanoparticles demonstrated successful transdermal delivery with sustained effects in early-stage testing
Food noise or hunger has returned: A sign that a dose is no longer sufficient is the return of intrusive thoughts about food or a noticeable decrease in feelings of fullness after meals
GLP-1 receptor agonists also exert antioxidant, anti-inflammatory, and antifibrotic effects by downregulating pro-inflammatory pathways (e.g., nuclear factor-B), cytokines (e.g., transforming growth factor ), and T-cell proliferation [18]
Being told no by an insurer is maddening
Safety Considerations and Provider Guidance for Medicaid-Covered GLP-1 Therapy GLP-1 medications carry important safety considerations that Medicaid programs evaluate during coverage review